By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AOP Orphan Pharmaceuticals AG 

A-1160 Wien
Wilhelminenstraße
Vienna    91/ II f / B4  Austria
Phone: 43-1-5037244-22 Fax: 43-1-5037244-61


SEARCH JOBS


Industry
Pharmaceutical






Company News
Partnership Between AOP Orphan Pharmaceuticals AG and Ferrer Internacional: Joint Marketing of Adasuve® in CEE 10/29/2013 8:45:51 AM
AOP Orphan Pharmaceuticals AG Announces Progress of Pivotal Phase III Trial PROUD-PV of Novel Mono-Pegylated Interferon Alpha 2b for the Treatment of Polycythemia Vera 10/10/2013 8:28:33 AM
AOP Orphan Pharmaceuticals AG Spins Off Its Stake in Activartis Biotech GmbH and Outlines Business Strategy 6/17/2013 11:19:56 AM
AOP Orphan Pharmaceuticals AG Release: Essential Thrombocythemia (ET) – Convincing Data of ANAHYDRET Study Now Published 3/18/2013 11:38:01 AM
AOP Orphan Pharmaceuticals AG Reports Positive Phase II Data of Novel Mono-Pegylated Interferon Alpha 2b for Treatment of Polycythemia Vera (PV) 12/10/2012 1:07:37 PM
Shield Signs Agreement for ST10-021 with AOP Orphan Pharmaceuticals AG 11/1/2010 1:15:42 PM
AOP Orphan Pharmaceuticals AG and Lantibio Inc. Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy 3/7/2007 10:16:31 AM
Novelix Pharmaceuticals Inc. Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals AG 2/26/2007 12:48:08 PM
AOP Orphan Pharmaceuticals And Lantibio, Inc. Announce A Licensing And Commercialization Agreement For Moli1901 In Cystic Fibrosis 10/19/2005 5:11:32 PM
AOP Orphan Pharmaceuticals AG Obtains Thromboreductin Registrations In Central Europe10/19/2005 5:08:57 PM
//-->